SMARCA2 (P51531) variants and mutations
SMARCA2 (also known as P51531) is a human protein-coding gene encoding a SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 protein. It provides ATP-dependent nucleosome remodeling activity to selected SWI/SNF complexes and helps control transcriptional access to chromatin. Heterozygous pathogenic variants cause Nicolaides-Baraitser syndrome or, through distinct mechanisms, blepharophimosis-intellectual-disability syndrome. This analysis covers 2,169 SMARCA2 variants and mutations. Of these, 66% have computational variant effect predictions. Disease context includes intellectual disability-sparse hair-brachydactyly syndrome, intellectual disability - sparse hair - brachydactyly, and blepharophimosis-impaired intellectual development syndrome. Example SMARCA2 variants include S2F, S2A, and S2Y.
Variant analysis overview
- Gene: SMARCA2
- Protein: P51531
- UniProt accession: P51531
- Organism: Homo sapiens
- Variants analyzed: 2169
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 1,850 unspecified-consequence records; 151 missense variants; 114 synonymous variants; 14 frameshift variants; 5 stop-gained variants; 1 protein altering variant; 17 in-frame deletions; 1 splice-region variants; 12 in-frame insertions; 4 substitution
- Prediction scores: 1,437 variants have prediction scores (66% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: intellectual disability-sparse hair-brachydactyly syndrome, intellectual disability - sparse hair - brachydactyly, blepharophimosis-impaired intellectual development syndrome, hereditary disease, Intellectual disability, blepharophimosis - intellectual disability syndrome, Coffin-Siris syndrome, Blepharophimosis-intellectual disability syndrome, neurodevelopmental disorder, gestational diabetes, Neurodevelopmental delay, vein of Galen aneurysm.
Protein structure and variant hotspots
- Protein features: 5 domains; 3 binding sites; 18 post-translational modification sites.
- Structural context: 642 variants have structural context.
- PTM context: 25 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable SMARCA2 variants
Examples include S2F, S2A, S2Y, S2C, T3M, T3K, T3T, P4L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S2F (p.Ser2Phe), Ensembl rs1818949787
- S2A (p.Ser2Ala), gnomAD 9-2029026-T-G, REVEL 0.25, AlphaMissense 0.11
- S2Y (p.Ser2Tyr), gnomAD 9-2029027-C-A, REVEL 0.49, AlphaMissense 0.79
- S2C (p.Ser2Cys), gnomAD 9-2029027-C-G, REVEL 0.46, AlphaMissense 0.42
- T3M (p.Thr3Met), rs1187602827, ClinGen CA372778971, ClinVar RCV002742350, TOPMed rs1187602827, REVEL 0.49, AlphaMissense 0.46, Likely benign, Inborn genetic diseases
- T3K (p.Thr3Lys), gnomAD 9-2029030-C-A, REVEL 0.58, AlphaMissense 0.85
- T3T (p.Thr3Thr), gnomAD 9-2029031-G-T, CADD 1.62
- P4L (p.Pro4Leu), TOPMed rs1182303341, REVEL 0.64, AlphaMissense 0.72
- P4T (p.Pro4Thr), gnomAD 9-2029032-C-A, REVEL 0.61, AlphaMissense 0.49
- P4S (p.Pro4Ser), gnomAD 9-2029032-C-T, REVEL 0.61, AlphaMissense 0.45
- P4P (p.Pro4Pro), rs762840154, gnomAD 9-2029034-C-T, CADD 12.90
- T5I (p.Thr5Ile), cosmic curated COSV10466
- T5S (p.Thr5Ser), gnomAD 9-2029035-A-T, REVEL 0.18, AlphaMissense 0.12
- T5A (p.Thr5Ala), gnomAD 9-2029035-A-G, REVEL 0.27, AlphaMissense 0.10
- T5T (p.Thr5Thr), rs1182185541, gnomAD 9-2029037-A-G, CADD 12.30
- D6N (p.Asp6Asn), cosmic curated COSV10649
- P7A (p.Pro7Ala), gnomAD rs1467981003, REVEL 0.32, AlphaMissense 0.08
- P7T (p.Pro7Thr), gnomAD 9-2029041-C-A, REVEL 0.33, AlphaMissense 0.08
- G8S (p.Gly8Ser), ExAC rs772087302, gnomAD rs772087302, REVEL 0.42, AlphaMissense 0.12
- G8C (p.Gly8Cys), gnomAD 9-2029044-G-T, REVEL 0.40, AlphaMissense 0.28
- G8D (p.Gly8Asp), gnomAD 9-2029045-G-A, REVEL 0.35, AlphaMissense 0.65
- G8G (p.Gly8Gly), gnomAD 9-2029046-T-G, CADD 5.85
- A9T (p.Ala9Thr), gnomAD rs1421915888, REVEL 0.22, AlphaMissense 0.14
- A9V (p.Ala9Val), rs773325366, NCI-TCGA Cosmic COSV6181, cosmic curated COSV61810, ClinVar RCV004581162, REVEL 0.25, AlphaMissense 0.22, Uncertain significance, not provided
- A9P (p.Ala9Pro), gnomAD 9-2029047-G-C, REVEL 0.25, AlphaMissense 0.20
- A9S (p.Ala9Ser), gnomAD 9-2029047-G-T, REVEL 0.18, AlphaMissense 0.09
- A9G (p.Ala9Gly), gnomAD 9-2029048-C-G, REVEL 0.28, AlphaMissense 0.09
- A9A (p.Ala9Ala), rs149689575, gnomAD 9-2029049-G-A, CADD 4.92
- M10I (p.Met10Ile), Ensembl rs1818951153
- M10L (p.Met10Leu), gnomAD rs1457819857
- M10V (p.Met10Val), gnomAD rs1457819857, REVEL 0.38, AlphaMissense 0.18
- P11H (p.Pro11His), cosmic curated COSV61814
- P11S (p.Pro11Ser), rs145516397, ClinGen CA4962739, ClinVar RCV002598994, ClinVar RCV005399119, REVEL 0.28, AlphaMissense 0.17, Benign/Likely benign, Inborn genetic diseases; not provided; Blepharophimosis-impaired intellectual de
- P11T (p.Pro11Thr), rs145516397, ClinGen CA372779018, ClinVar RCV000626169, 1000Genomes rs145516397, AlphaMissense 0.17, MetaLR 0.51, Uncertain significance, Nicolaides-Baraitser syndrome
- P11P (p.Pro11Pro), rs754052480, gnomAD 9-2029055-C-T, CADD 13.60
- H12R (p.His12Arg), TOPMed rs1450657913, gnomAD rs1450657913, REVEL 0.30, AlphaMissense 0.53, Uncertain significance, Inborn genetic diseases
- H12P (p.His12Pro), gnomAD 9-2029052-GCC-G, CADD 27.00
- H12T (p.His12Thr), gnomAD 9-2029052-GC-G, CADD 26.20
- H12N (p.His12Asn), gnomAD 9-2029056-C-A, REVEL 0.34, AlphaMissense 0.39
- H12D (p.His12Asp), gnomAD 9-2029056-C-G, REVEL 0.49, AlphaMissense 0.84
- H12Y (p.His12Tyr), gnomAD 9-2029056-C-T, REVEL 0.42, AlphaMissense 0.36
- H12Q (p.His12Gln), gnomAD 9-2029058-C-A, REVEL 0.49, AlphaMissense 0.54
- P13A (p.Pro13Ala), Ensembl rs1818951629, REVEL 0.30, AlphaMissense 0.13
- P13R (p.Pro13Arg), gnomAD 9-2029057-ACC-A, CADD 25.90
- P13T (p.Pro13Thr), gnomAD 9-2029059-C-A, REVEL 0.36, AlphaMissense 0.22
- P13P (p.Pro13Pro), rs1563716357, gnomAD 9-2029061-A-T, CADD 6.47
- G14R (p.Gly14Arg), cosmic curated COSV61812, REVEL 0.69, AlphaMissense 0.93
- G14E (p.Gly14Glu), gnomAD 9-2029063-G-A, REVEL 0.65, AlphaMissense 0.91
- G14G (p.Gly14Gly), gnomAD 9-2029064-G-A, CADD 11.50
- P15L (p.Pro15Leu), TOPMed rs983619382
- P15T (p.Pro15Thr), gnomAD 9-2029065-C-A, REVEL 0.60, AlphaMissense 0.55
- P15A (p.Pro15Ala), gnomAD 9-2029065-C-G, REVEL 0.55, AlphaMissense 0.33
- P15S (p.Pro15Ser), gnomAD 9-2029065-C-T, REVEL 0.50, AlphaMissense 0.54
- P15P (p.Pro15Pro), gnomAD 9-2029067-T-A, CADD 10.70
- S16L (p.Ser16Leu), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, Ensembl rs2130178649, REVEL 0.65, AlphaMissense 0.79, Variant assessed as somatic; moderate impact.
- S16S (p.Ser16Ser), rs760000638, gnomAD 9-2029070-G-A, CADD 8.36
- P17L (p.Pro17Leu), rs543241889, ClinGen CA4962743, ClinVar RCV001546011, ClinVar RCV004039270, REVEL 0.54, AlphaMissense 0.68, Likely benign, Inborn genetic diseases; not provided
- P17Q (p.Pro17Gln), 1000Genomes rs543241889, ExAC rs543241889, TOPMed rs543241889, gnomAD rs543241889, REVEL 0.46, AlphaMissense 0.69, Likely benign
- P17S (p.Pro17Ser), TOPMed rs1818952140, REVEL 0.53, AlphaMissense 0.60
- P17T (p.Pro17Thr), gnomAD 9-2029071-C-A, REVEL 0.53, AlphaMissense 0.64
- P17R (p.Pro17Arg), gnomAD 9-2029072-C-G, REVEL 0.63, AlphaMissense 0.80
- P17P (p.Pro17Pro), rs148865068, gnomAD 9-2029073-G-A, CADD 1.31
- G18E (p.Gly18Glu), rs2537192540, ClinGen CA372779062, ClinVar RCV003580630, Benign, not provided
- G18V (p.Gly18Val), cosmic curated COSV10744
- G18G (p.Gly18Gly), rs976156529, gnomAD 9-2029076-G-T, CADD 9.76
- P19S (p.Pro19Ser), ExAC rs777207780, gnomAD rs777207780, REVEL 0.34, AlphaMissense 0.23
- P19L (p.Pro19Leu), gnomAD 9-2029078-C-T, REVEL 0.46, AlphaMissense 0.28
- G20W (p.Gly20Trp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G20V (p.Gly20Val), gnomAD 9-2029081-G-T, REVEL 0.62, AlphaMissense 0.58
- G20G (p.Gly20Gly), rs1052098467, gnomAD 9-2029082-G-C, CADD 4.94
- P21A (p.Pro21Ala), Ensembl rs1331700267
- P21H (p.Pro21His), ExAC rs776972919, gnomAD rs776972919, REVEL 0.42, AlphaMissense 0.45, Uncertain significance, Inborn genetic diseases
- P21L (p.Pro21Leu), gnomAD 9-2029084-C-T, REVEL 0.28, AlphaMissense 0.14
- P21P (p.Pro21Pro), rs756655795, gnomAD 9-2029085-T-A, CADD 11.40
- S22F (p.Ser22Phe), cosmic curated COSV10524
- S22S (p.Ser22Ser), rs780915633, gnomAD 9-2029088-C-T, CADD 5.74
- P23S (p.Pro23Ser), rs2537192615, ClinGen CA372779089, ClinVar RCV003127247, Likely benign, Autism spectrum disorder
- P23T (p.Pro23Thr), gnomAD 9-2029089-C-A, REVEL 0.52, AlphaMissense 0.73
- P23P (p.Pro23Pro), gnomAD 9-2029091-T-G, CADD 9.02
- G24E (p.Gly24Glu), TOPMed rs1236752228, gnomAD rs1236752228, REVEL 0.61, AlphaMissense 0.95
- G24R (p.Gly24Arg), NCI-TCGA TCGA novel, REVEL 0.65, AlphaMissense 0.96, Variant assessed as somatic; moderate impact.
- G24W (p.Gly24Trp), cosmic curated COSV10968
- G24V (p.Gly24Val), gnomAD 9-2029093-G-T, REVEL 0.61, AlphaMissense 0.78
- P25A (p.Pro25Ala), Ensembl rs1818953476, REVEL 0.33, AlphaMissense 0.21
- P25T (p.Pro25Thr), gnomAD 9-2029095-C-A, REVEL 0.37, AlphaMissense 0.37
- P25L (p.Pro25Leu), gnomAD 9-2029096-C-T, REVEL 0.43, AlphaMissense 0.56
- I26L (p.Ile26Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- I26T (p.Ile26Thr), rs1184325506, ClinGen CA372779109, ClinVar RCV003665869, TOPMed rs1184325506, REVEL 0.46, AlphaMissense 0.93, Uncertain significance, not provided
- I26V (p.Ile26Val), gnomAD rs1482147918, REVEL 0.36, AlphaMissense 0.26
- I26F (p.Ile26Phe), gnomAD 9-2029098-A-T, REVEL 0.39, AlphaMissense 0.40
- L27F (p.Leu27Phe), NCI-TCGA Cosmic COSV6180, Variant assessed as somatic; moderate impact.
- L27I (p.Leu27Ile), NCI-TCGA Cosmic COSV6180, cosmic curated COSV61804, REVEL 0.34, AlphaMissense 0.27, Variant assessed as somatic; moderate impact.
- L27P (p.Leu27Pro), gnomAD 9-2029102-T-C, REVEL 0.46, AlphaMissense 0.58
- G28W (p.Gly28Trp), cosmic curated COSV10057
- G28G (p.Gly28Gly), gnomAD 9-2029106-G-T, CADD 3.73
- P29L (p.Pro29Leu), gnomAD rs1412585591, REVEL 0.57, AlphaMissense 0.73, Uncertain significance, not specified
- P29H (p.Pro29His), gnomAD 9-2029108-C-A, REVEL 0.50, AlphaMissense 0.73
- S30N (p.Ser30Asn), TOPMed rs1818953876, REVEL 0.43, AlphaMissense 0.86
- S30R (p.Ser30Arg), gnomAD 9-2029110-A-C, REVEL 0.46, AlphaMissense 0.97
- S30T (p.Ser30Thr), gnomAD 9-2029111-G-C, REVEL 0.46, AlphaMissense 0.47
- P31L (p.Pro31Leu), gnomAD rs868162385, REVEL 0.49, AlphaMissense 0.53
- P31S (p.Pro31Ser), rs1158455540, NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, gnomAD rs1158455540, AlphaMissense 0.32, MetaLR 0.78, Variant assessed as somatic; moderate impact.
- P31Q (p.Pro31Gln), gnomAD 9-2029114-C-A, REVEL 0.45, AlphaMissense 0.46
- G32R (p.Gly32Arg), gnomAD rs1818954306, REVEL 0.58, AlphaMissense 0.91
- G32V (p.Gly32Val), gnomAD 9-2029117-G-T, REVEL 0.60, AlphaMissense 0.46
- G32G (p.Gly32Gly), gnomAD 9-2029118-A-G, CADD 8.12
- P33R (p.Pro33Arg), TOPMed rs1469165256, gnomAD rs1469165256, REVEL 0.57, AlphaMissense 0.53
- P33S (p.Pro33Ser), rs146990134, ClinGen CA4962751, ClinVar RCV000263654, ClinVar RCV001653759, REVEL 0.39, AlphaMissense 0.18, Benign/Likely benign, Inborn genetic diseases; not provided; Nicolaides-Baraitser syndrome
- P33A (p.Pro33Ala), gnomAD 9-2029119-C-G, REVEL 0.36, AlphaMissense 0.14
- P33L (p.Pro33Leu), gnomAD 9-2029120-C-T, REVEL 0.50, AlphaMissense 0.32
- P33Q (p.Pro33Gln), gnomAD 9-2029120-C-A, REVEL 0.35, AlphaMissense 0.27
- P33P (p.Pro33Pro), rs2130179011, gnomAD 9-2029121-A-G, CADD 1.93
- G34* (p.Gly34Ter), gnomAD 9-2029122-G-T, CADD 37.00
- P35L (p.Pro35Leu), rs749279138, ClinGen CA4962754, ClinVar RCV003546416, ClinVar RCV006262835, REVEL 0.33, AlphaMissense 0.12, Conflicting interpretations, not specified; not provided
- P35S (p.Pro35Ser), rs562820489, NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, 1000Genomes rs562820489, REVEL 0.40, AlphaMissense 0.21, Variant assessed as somatic; moderate impact.
- P35T (p.Pro35Thr), 1000Genomes rs562820489, ExAC rs562820489, gnomAD rs562820489
- P35A (p.Pro35Ala), gnomAD 9-2029125-C-G, REVEL 0.40, AlphaMissense 0.13
- P35Q (p.Pro35Gln), gnomAD 9-2029126-C-A, REVEL 0.35, AlphaMissense 0.25
- P35P (p.Pro35Pro), rs1039400951, gnomAD 9-2029127-A-G, CADD 6.44
- S36P (p.Ser36Pro), cosmic curated COSV61811
- S36T (p.Ser36Thr), gnomAD 9-2029128-T-A, REVEL 0.36, AlphaMissense 0.39
- S36S (p.Ser36Ser), gnomAD 9-2029130-C-T, CADD 8.69
- P37T (p.Pro37Thr), gnomAD 9-2029131-C-A, REVEL 0.51, AlphaMissense 0.51
- P37Q (p.Pro37Gln), gnomAD 9-2029132-C-A, REVEL 0.46, AlphaMissense 0.59
- P37L (p.Pro37Leu), gnomAD 9-2029132-C-T, REVEL 0.41, AlphaMissense 0.60
- G38A (p.Gly38Ala), ExAC rs774085434, gnomAD rs774085434, REVEL 0.39, AlphaMissense 0.17, Uncertain significance
- G38C (p.Gly38Cys), rs768632343, NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, ExAC rs768632343, REVEL 0.59, AlphaMissense 0.26, Uncertain significance, Nicolaides-Baraitser syndrome
- G38D (p.Gly38Asp), rs774085434, ClinGen CA372779177, ClinVar RCV003562298, ExAC rs774085434, REVEL 0.48, AlphaMissense 0.83, Likely benign, not provided
- G38F (p.Gly38Phe), cosmic curated COSV61806
- G38V (p.Gly38Val), rs774085434, NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, ExAC rs774085434, REVEL 0.51, AlphaMissense 0.38, Uncertain significance
- S39F (p.Ser39Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S39S (p.Ser39Ser), rs760818868, gnomAD 9-2029139-C-T, CADD 7.64
- V40I (p.Val40Ile), rs374826893, ClinGen CA4962758, cosmic curated COSV10968, ClinVar RCV002881795, REVEL 0.19, AlphaMissense 0.14, Likely benign, Inborn genetic diseases; not provided
- H41Y (p.His41Tyr), Ensembl rs1818955470
- H41H (p.His41His), gnomAD 9-2029145-C-T, CADD 11.70
- S42N (p.Ser42Asn), ExAC rs777024299, gnomAD rs777024299, REVEL 0.42, AlphaMissense 0.42
- M43T (p.Met43Thr), cosmic curated COSV10057, gnomAD rs1818955638, REVEL 0.36, AlphaMissense 0.85
- M43V (p.Met43Val), gnomAD 9-2029149-A-G, REVEL 0.48, AlphaMissense 0.19
- M43L (p.Met43Leu), gnomAD 9-2029149-A-T, REVEL 0.46, AlphaMissense 0.25
- M43I (p.Met43Ile), gnomAD 9-2029151-G-A, REVEL 0.44, AlphaMissense 0.78
- M44V (p.Met44Val), rs531812409, ClinGen CA4962760, ClinVar RCV003843211, 1000Genomes rs531812409, REVEL 0.49, AlphaMissense 0.44, Benign, not provided
- G45A (p.Gly45Ala), rs1219506276, ClinGen CA372779226, ClinVar RCV003568777, REVEL 0.55, AlphaMissense 0.78, Likely benign, not provided
- G45E (p.Gly45Glu), gnomAD rs1219506276, REVEL 0.67, AlphaMissense 0.98
- G45W (p.Gly45Trp), gnomAD 9-2029155-G-T, REVEL 0.64, AlphaMissense 0.97
- G45G (p.Gly45Gly), gnomAD 9-2029157-G-C, CADD 9.79
- P46L (p.Pro46Leu), ExAC rs765745579, gnomAD rs765745579, REVEL 0.63, AlphaMissense 0.76
- P46R (p.Pro46Arg), ExAC rs765745579, gnomAD rs765745579, REVEL 0.66, AlphaMissense 0.85
- P46S (p.Pro46Ser), cosmic curated COSV61804, Ensembl rs1563716507, REVEL 0.53, AlphaMissense 0.70, Uncertain significance, Intellectual disability
- P46P (p.Pro46Pro), rs1440530813, gnomAD 9-2029160-A-G, CADD 5.95
- S47G (p.Ser47Gly), ExAC rs775986079, gnomAD rs775986079, REVEL 0.40, AlphaMissense 0.64
- S47N (p.Ser47Asn), gnomAD 9-2029162-G-A, REVEL 0.41, AlphaMissense 0.91
- P48L (p.Pro48Leu), NCI-TCGA Cosmic COSV6181, cosmic curated COSV61813, Variant assessed as somatic; moderate impact.
- P48R (p.Pro48Arg), rs1818956557, ClinGen CA372779245, ClinVar RCV002509972, TOPMed rs1818956557, AlphaMissense 0.80, MetaLR 0.81, Uncertain significance, not provided
- P48S (p.Pro48Ser), gnomAD rs1252482007, REVEL 0.46, AlphaMissense 0.39, Likely benign, not provided; Inborn genetic diseases
- P48T (p.Pro48Thr), gnomAD 9-2029164-C-A, REVEL 0.47, AlphaMissense 0.47
- P48P (p.Pro48Pro), rs1482652997, gnomAD 9-2029166-T-C, CADD 7.29
- G49R (p.Gly49Arg), gnomAD 9-2029167-G-A, REVEL 0.57, AlphaMissense 0.95
- G49G (p.Gly49Gly), gnomAD 9-2029169-A-G, CADD 9.29
- P50H (p.Pro50His), TOPMed rs1818956969
- P50R (p.Pro50Arg), TOPMed rs1818956969
- P50S (p.Pro50Ser), TOPMed rs1181552796, gnomAD rs1181552796, REVEL 0.52, AlphaMissense 0.27
- P50L (p.Pro50Leu), gnomAD 9-2029171-C-T, REVEL 0.56, AlphaMissense 0.30
- P51Q (p.Pro51Gln), gnomAD rs1231313930
- P51P (p.Pro51Pro), gnomAD 9-2029175-A-C, CADD 1.26
- S52G (p.Ser52Gly), rs763439455, ClinGen CA4962763, ClinVar RCV002290908, ExAC rs763439455, REVEL 0.34, AlphaMissense 0.08, Uncertain significance, not provided
- S52R (p.Ser52Arg), gnomAD rs1173425733
- S52T (p.Ser52Thr), rs2537192938, ClinGen CA372779268, ClinVar RCV003556628, Uncertain significance, not provided
- S52N (p.Ser52Asn), gnomAD 9-2029177-G-A, REVEL 0.30, AlphaMissense 0.18
- V53I (p.Val53Ile), 1000Genomes rs191818866, ExAC rs191818866, gnomAD rs191818866, REVEL 0.38, AlphaMissense 0.09
- V53G (p.Val53Gly), gnomAD 9-2029180-T-G, REVEL 0.42, AlphaMissense 0.22
- V53V (p.Val53Val), rs751953852, gnomAD 9-2029181-C-G, CADD 6.29
- S54F (p.Ser54Phe), cosmic curated COSV10524, REVEL 0.21, AlphaMissense 0.33
- S54T (p.Ser54Thr), gnomAD 9-2029182-T-A, REVEL 0.28, AlphaMissense 0.08
- S54Y (p.Ser54Tyr), gnomAD 9-2029183-C-A, REVEL 0.18, AlphaMissense 0.35
- S54S (p.Ser54Ser), rs1252230463, gnomAD 9-2029184-C-T, CADD 1.32
- P56H (p.Pro56His), TOPMed rs893093652, gnomAD rs893093652, REVEL 0.28, AlphaMissense 0.12, Uncertain significance, not provided
- P56R (p.Pro56Arg), TOPMed rs893093652, gnomAD rs893093652, REVEL 0.27, AlphaMissense 0.30
- P56S (p.Pro56Ser), rs1448350538, NCI-TCGA Cosmic COSV6181, cosmic curated COSV61813, TOPMed rs1448350538, AlphaMissense 0.05, MetaLR 0.38, Variant assessed as somatic; moderate impact.
- P58L (p.Pro58Leu), rs764338204, ClinGen CA4962766, ClinVar RCV001942824, ExAC rs764338204, REVEL 0.33, AlphaMissense 0.16, Likely benign, not provided
- P58R (p.Pro58Arg), ExAC rs764338204, TOPMed rs764338204, gnomAD rs764338204, REVEL 0.36, AlphaMissense 0.37, Likely benign
Public SMARCA2 analysis runs
- SMARCA2 analysis run — SMARCA2 (2,169 variants) — completed 2026-08-20